PMS-Repaglinide Drug Information [ Pharmascience ]
Table of content
PMS-Repaglinide category:
Active ingredients:
PMS-Repaglinide companies and manufacturers:
General Information
PMS-Repaglinide forms, composition and dosages:
- Tablets; Oral; Repaglinide 0.5 mg
- Tablets; Oral; Repaglinide 1 mg
- Tablets; Oral; Repaglinide 2 mg
Indications, usages and classification codes:
- A10BX02 - Repaglinide
PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
- Hipover Drugtech Laboratorio; Recalcine Laboratorios
- NovoNorm Novo Nordisk; Pisa Laboratorios
- Prandin Novo Nordisk; Medley Industria Farmaceutica; Menarini; Novo Nordisk; Sanfer Laboratorios; Sankyo
- Rapilin Sun Pharmaceutical Industries
- Regan Ranbaxy
- Repaglinide Caraco
- Sestrine Beta Laboratorios
- Actulin
- CO Repaglinide Cobalt Pharmaceuticals
- Dexanorm Dexa Medica Pharm & Chem
- Dopect Domesco Medical Import-Export
- Eurepa Torrent Pharmaceuticals
- Hipover Drugtech Laboratorio; Recalcine Laboratorios
- NovoNorm Novo Nordisk; Agencia Lei Va Hong; DKSH; Metro Drug Distribution; Pisa Laboratorios
- Page Orchid Chemicals & Pharmaceuticals
- Prandin Novo Nordisk; Medley Industria Farmaceutica; Menarini; Sanfer Laboratorios; Sankyo
- Q-Repa Q Check Speciality Care
- Repa Orchid Chemicals & Pharmaceuticals
- Repide Wallace Pharmaceuticals
- Restrict East West Pharma
- 1 M-Kalium-L-Malat-Loesung Salvia Baxter
- 1 M-L-Argininhydrochlorid Baxter
- 1 M-Natriumchlorid-Loesung Salvia Baxter
- 102 Anos Instituto Seroterapico Argentino
- 12 Hour Antihistamine Nasal Decongestant United Research Laboratories
- 12 Hour Cold Goldline
- 12 Hour Sinarest Novartis
- 12 in / Dans 1 Delano Health Products
- 12 Sels de Schuessler Dolisos
- 12070 Blue BCM
- 125 FL Moisture Whip Lipstick Maybelline
- 1311 Blue BCM
- 14-Day Skin Rescue SPF 30 Johnson & Johnson
- 16-08 Nickel Kroeger Herb Products
- 18 Essential Vitamins and Minerals Stanley Pharmaceuticals
- 18F-FDG BSM Diagnostica
- 1903 Yellow Pink BCM
- 1-Alpha Leo Pharma
- 1-Carpserp BCM
- 1st Foods Novartis